NCT04001439 is a NA clinical trial of Experimental drug in Depression in Schizophrenia, sponsored by Assistance Publique Hopitaux De Marseille.

Who is sponsoring NCT04001439?

NCT04001439 is sponsored by Assistance Publique Hopitaux De Marseille.

What drugs are being tested in NCT04001439?

Interventions in NCT04001439: Experimental drug.

What condition does NCT04001439 study?

NCT04001439 studies Depression in Schizophrenia.

Is NCT04001439 still recruiting?

NCT04001439 is currently status unknown. Last updated 28 June 2019.

Last reviewed 2019-06-28 · How we verify

NCT04001439

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FEcal Microbiota Transplantation

Status unknown NA Last updated 28 June 2019

What this trial tests

NA trial testing Experimental drug in Depression in Schizophrenia in 3,088 participants. Status unknown.

Timeline

1 December 2019

Primary endpoint
1 February 2020

31 December 2020

Quick facts

Lead sponsor	Assistance Publique Hopitaux De Marseille
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	3,088
Start date	1 December 2019
Primary completion	1 February 2020
Estimated completion	31 December 2020

Drugs / interventions tested

Experimental drug — full drug profile →

Conditions studied

Depression in Schizophrenia — all drugs for Depression in Schizophrenia →

Sponsor

Assistance Publique Hopitaux De Marseille — full company profile →

Who can join

Adults 18 to 65, any sex, with Depression in Schizophrenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective will be to evaluate effectiveness, safety and acceptability of FMT on depressive symptoms at 2 months follow-up in SZ patients with resistant MD.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fecal Microbiota Transplantation: A New Therapeutic Attempt from the Gut to the Brain.
Xu HM, Huang HL, Zhou YL, Zhao HL, et al · · 2021 · cited 59× · PMID 33510784 · DOI 10.1155/2021/6699268

Verify or expand the search:

Other trials of Experimental drug

Trials testing the same drug.

NCT06752382 — Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPC · Phase 2 · not yet recruiting
NCT05409417 — Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal · Phase 2, PHASE3 · unknown
NCT05451654 — NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evalu · Phase 1, PHASE2 · terminated
NCT04357613 — IMATINIB IN COVID-19 DISEASE IN AGED PATIENTS. · Phase 2 · unknown
NCT03821870 — Predictive Value of Analysing Tissue From Patients With Metastatic Pancreatic Cancer for Drug Sensitivity · completed

Other Assistance Publique Hopitaux De Marseille trials

Trials by the same sponsor.

NCT07521644 — Dysbiosis of Methanogenic Archaea and Nanoarchaea in the Oral Microbiome · NA · not yet recruiting
NCT07357025 — Resting-State fMRI Study of Functional Connectivity After Gamma Knife Radiosurgery in Trigeminal Neuralgia · NA · not yet recruiting
NCT07356661 — Evaluation of the Efficacy of Neurofeedback Technique Based on EEG Desynchronization in Epileptic Patients · NA · not yet recruiting
NCT07399327 — Biomarkers of Response to SEEG Thermocoagulation · NA · not yet recruiting
NCT06999499 — Development of an Aid to Melanoma Detection Using Artificial Intelligence Algorithms Based on Images From the VECTRA 3D · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04001439 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique Hopitaux De Marseille
Last refreshed: 28 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04001439.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing